IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols
Recruiting now · Not applicable
Conditions studied: Infertility (IVF Patients), Embryo Morphokinetics, Progestins Primed Ovarian Stimulation
In brief
The goal of this clinical trial is to compare two ovarian stimulation protocols used in in vitro fertilization (IVF): the fixed Progestin-Primed Ovarian Stimulation (PPOS) protocol and the GnRH Antagonist protocol. The study will evaluate IVF outcomes and embryo development patterns using time-lapse embryo monitoring technology. The main questions the study aims to answer are: * Does the fixed - PPOS protocol achieve similar numbers of mature eggs, good-quality embryos, and clinical outcomes compared to the GnRH Antagonist protocol? * Are there differences in embryo development patterns (morphokinetics) between the two protocols when monitored by time-lapse imaging? * How does embryo quality (KIDScore) compare between the two protocols? Study Design: Researchers will randomly assign 148 women undergoing IVF to two groups: * PPOS group (n=74): Will receive FSH injections (oral Duphaston 20mg daily) starting from day 2-3 of the menstrual cycle * GnRH Antagonist group (n=74): Will receive FSH injections (Orgalutran 0.25mg injections) when follicles reach ≥14mm Participants will: * Undergo controlled ovarian stimulation with their assigned protocol for approximately 10-12 days * Have regular ultrasound monitoring and blood tests to track follicle development * Undergo egg retrieval procedure when follicles are mature * Have all embryos cultured in the EmbryoScope time-lapse incubator with continuous monitoring * Have embryos frozen on Day 5/6 for future transfer Study Location: Department of Assisted Reproduction and Andrology, Hanoi Obstetrics and Gynecology Hospital Study Duration: January 2026 - June 2028
Key facts
- Study ID
- NCT07409493
- Run by
- Hanoi Medical University
- People needed
- 148
- Starts
- 2026-01-21
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2026-02-13
Who can join
Age: 20 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women aged 20-45 years
- Indicated for in vitro fertilization (IVF) treatment
- Planned freeze-all embryo strategy
- Voluntary participation in research.
You may not qualify if…
- Systemic diseases
- Use of hormonal medications within 3 months prior to enrollment
- Oocyte donation cycles
- Unwilling or unable to participate in research
Where it is running
- Hanoi Obstetrics and Gynecology Hospital — Hanoi, Vietnam (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.